32 research outputs found
Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ
Major stages of the pathogenesis of true acantholytic pemphigus are interpreted in terms of autoimmune pathology; therefore, treatment of this group of diseases remains pathogenetic and is aimed at suppressing the synthesis of autoantibodies against keratinocyte proteins. Treatment with the use of systemic glucocorticosteroids is currently the main method of treatment for true acantholytic pemphigus. To reduce the course dose of glucocorticosteroids, decrease the risk of adverse effect development and achieve long-term remission, further studies of disease pathogenesis and development of new treatment methods for reducing the doses of glucocorticosteroids are of great importance.ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ Π·Π²Π΅Π½ΡΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π° ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ ΡΡΠ°ΠΊΡΡΡΡΡΡ Ρ ΠΏΠΎΠ·ΠΈΡΠΈΠΉ Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ, ΠΏΠΎΡΡΠΎΠΌΡ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π΄Π°Π½Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΎΡΡΠ°Π΅ΡΡΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΌ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΠΌ Π½Π° ΠΏΠΎΠ΄Π°Π²Π»Π΅Π½ΠΈΠ΅ ΡΠΈΠ½ΡΠ΅Π·Π° Π°ΡΡΠΎΠ°Π½ΡΠΈΡΠ΅Π» ΠΊ Π±Π΅Π»ΠΊΠ°ΠΌ ΠΊΠ΅ΡΠ°ΡΠΈΠ½ΠΎΡΠΈΡΠΎΠ². Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠΈΡΡΠ΅ΠΌΠ½ΡΡ
Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΊΠΎΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ². Π‘ ΡΠ΅Π»ΡΡ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΠΊΡΡΡΠΎΠ²ΡΡ
Π΄ΠΎΠ· Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΊΠΎΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ², ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΡ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠΎΠ±ΠΎΡΠ½ΡΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ ΠΈ Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΠΌΠΈΡΡΠΈΠΈ Π²Π°ΠΆΠ½ΡΠΌΠΈ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡΠΌΠΈ ΡΠ²Π»ΡΡΡΡΡ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° Π½ΠΎΠ²ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡΠΈΡ
ΡΠ½ΠΈΠ·ΠΈΡΡ Π΄ΠΎΠ·Ρ Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΊΠΎΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ²
ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΈΠ½Π΄Π΅ΠΊΡΠΎΠ² Π² ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΡΠΆΠ΅ΡΡΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ (ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·)
The article discusses clinical indices suggested for the assessment of the severity of the course of autoimmune bullous dermatosis - pemphigus. These indices make it possible to assess the severity of the disease in view of the localization and prevalence of blisters and/or erosions and patientβs subjective sensations as well as efficacy of the therapy, and to compare the study results. In spite of the great number of indices suggested for the assessment of the severity of pemphigus, none of them are generally recognized. The following indices are currently considered as the best known and most convenient for application in clinical practice: Pemphigus Disease Area Index (PDAI), Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Vulgaris Activity Score (PVAS). A number of studies demonstrated mutual correlation among ABSIS, PDAI and PVAS. However, the group of patients under examination mainly comprised people suffering from light to moderate forms of pemphigus, which makes it difficult to interpret the results of comparative studies. It is expedient for leading dermatovenerologists to carry out clinical studies based on a large group of patients with pemphigus of different severity to elaborate a common tool to assess the severity of pemphigus in the Russian Federation to be recommended by the Russian Society of Dermatovenerologists.Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠ½Π΄Π΅ΠΊΡΡ, ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½ΡΠ΅ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΡΡΠΆΠ΅ΡΡΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΠΎΠ³ΠΎ Π±ΡΠ»Π»Π΅Π·Π½ΠΎΠ³ΠΎ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ·Π° - ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ. ΠΠ½Π΄Π΅ΠΊΡΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ ΠΎΡΠ΅Π½ΠΈΠ²Π°ΡΡ ΡΡΠΆΠ΅ΡΡΡ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Ρ ΡΡΠ΅ΡΠΎΠΌ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΈ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ ΠΏΡΠ·ΡΡΠ΅ΠΉ ΠΈ/ΠΈΠ»ΠΈ ΡΡΠΎΠ·ΠΈΠΉ ΠΈ ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
ΠΎΡΡΡΠ΅Π½ΠΈΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°, ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, ΡΡΠ°Π²Π½ΠΈΠ²Π°ΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Π½Π°ΡΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° Π±ΠΎΠ»ΡΡΠΎΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½ΡΡ
ΠΈΠ½Π΄Π΅ΠΊΡΠΎΠ² ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΠΆΠ΅ΡΡΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ, Π½ΠΈ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· Π½ΠΈΡ
Π½Π΅ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ·Π½Π°Π½Π½ΡΠΌ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΠΌΠΈ ΠΈ ΡΠ΄ΠΎΠ±Π½ΡΠΌΠΈ ΠΊ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΏΡΠΈΠ·Π½Π°ΡΡΡΡ: ΠΈΠ½Π΄Π΅ΠΊΡ ΠΏΠ»ΠΎΡΠ°Π΄ΠΈ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΏΡΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠ΅ (PDAI), ΠΎΡΠ΅Π½ΠΊΠ° ΡΡΠΆΠ΅ΡΡΠΈ Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΡΡ
Π±ΡΠ»Π»Π΅Π·Π½ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΊΠΎΠΆΠΈ (ABSIS), ΠΎΡΠ΅Π½ΠΊΠ° Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π²ΡΠ»ΡΠ³Π°ΡΠ½ΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ (PVAS). Π ΡΡΠ΄Π΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π½Π° ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΡ ABSIS, PDAI, PVAS ΠΌΠ΅ΠΆΠ΄Ρ ΡΠΎΠ±ΠΎΠΉ. ΠΠ΄Π½Π°ΠΊΠΎ ΠΊΠΎΠ½ΡΠΈΠ½Π³Π΅Π½Ρ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ Π²ΠΊΠ»ΡΡΠ°Π» Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ Ρ Π»Π΅Π³ΠΊΠΎΠΉ ΠΈ ΡΡΠ΅Π΄Π½Π΅ΠΉ ΡΡΠΆΠ΅ΡΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΡΡΠΎ Π·Π°ΡΡΡΠ΄Π½ΡΠ΅Ρ ΠΈΠ½ΡΠ΅ΡΠΏΡΠ΅ΡΠ°ΡΠΈΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ ΡΠ΅Π»Π΅ΡΠΎΠΎΠ±ΡΠ°Π·Π½ΡΠΌ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ Π²Π΅Π΄ΡΡΠΈΠΌΠΈ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠ°ΠΌΠΈ-Π΄Π΅ΡΠΌΠ°ΡΠΎΠ²Π΅Π½Π΅ΡΠΎΠ»ΠΎΠ³Π°ΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π½Π° Π±ΠΎΠ»ΡΡΠΎΠΌ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠΉ ΡΡΠΆΠ΅ΡΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π² ΡΠ΅Π»ΡΡ
ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ Π΅Π΄ΠΈΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠ° ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΠΆΠ΅ΡΡΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ Π² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ Π΄Π»Ρ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ ΠΊ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π ΠΎΡΡΠΈΠΉΡΠΊΠΈΠΌ ΠΎΠ±ΡΠ΅ΡΡΠ²ΠΎΠΌ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ²Π΅Π½Π΅ΡΠΎΠ»ΠΎΠ³ΠΎΠ²
ΠΠΊΡΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΊΠ΅ΡΠ°ΡΠΎΠ·: ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠΉ Π²Π·Π³Π»ΡΠ΄ Π½Π° ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ
The article summarizes information about the actinic keratosis. Presented data of the literature aboutΒ the prevalence of the disease, the features of the clinical picture, diagnosis, differential diagnosis andΒ treatment of dermatosis.Π ΡΡΠ°ΡΡΠ΅ ΠΎΠ±ΠΎΠ±ΡΠ΅Π½Ρ ΡΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΎΠ± Π°ΠΊΡΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΊΠ΅ΡΠ°ΡΠΎΠ·Π΅, ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅Β Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ, ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΡΠ΅ Π²ΠΎΠΏΡΠΎΡΠ°ΠΌ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉΒ ΠΊΠ°ΡΡΠΈΠ½Ρ, Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ, Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ; ΠΎΡΡΠ°ΠΆΠ΅Π½Ρ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ ΡΠ΅ΡΠ°ΠΏΠΈΠΈΒ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ
ΠΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΏΡΠ·ΡΡΠ½ΡΡ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ·ΠΎΠ²
Bullous dermatoses are the diseases characterized by vesication and erosion of skin and/or mucos coats, production of autoantibodies against the structural components of epidermis and/or derma. The most frequent diseases of these disorders are pemphigus, bullous pemphigoid, dermatitis herpetiformis, beningn familial chronic pemphigus (Gougerot Hailey-Hailey disease).Diagnostics of bullous dermatoses is based on assessement of clinical signs, results of cytological and histological studies and immunological tests. However none of the current diagnostic methods allows to reveal bullous dermatosis severally and with absolute certainty. Consequently it is necessary to perform wide range of clinical and laboratory tests for early diagnosis and treatment order.ΠΡΠ·ΡΡΠ½ΡΠ΅ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ·Ρ - Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠΈΠ΅ΡΡ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠ·ΡΡΠ΅ΠΉ ΠΈ ΡΡΠΎΠ·ΠΈΠΉ Π½Π° ΠΊΠΎΠΆΠ΅ ΠΈ/ΠΈΠ»ΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠ°Ρ
, Π²ΡΡΠ°Π±ΠΎΡΠΊΠΎΠΉ Π°ΡΡΠΎΠ°Π½ΡΠΈΡΠ΅Π» ΠΊ ΡΡΡΡΠΊΡΡΡΠ½ΡΠΌ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ°ΠΌ ΡΠΏΠΈΠ΄Π΅ΡΠΌΠΈΡΠ° ΠΈ/ΠΈΠ»ΠΈ Π΄Π΅ΡΠΌΡ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ Π²ΡΡΡΠ΅ΡΠ°ΡΡΠΈΠΌΠΈΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ ΠΈΠ· ΡΡΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΡΠ²Π»ΡΡΡΡΡ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠ°, Π±ΡΠ»Π»Π΅Π·Π½ΡΠΉ ΠΏΠ΅ΠΌΡΠΈΠ³ΠΎΠΈΠ΄, Π³Π΅ΡΠΏΠ΅ΡΠΈΡΠΎΡΠΌΠ½ΡΠΉ Π΄Π΅ΡΠΌΠ°ΡΠΈΡ, ΡΠ΅ΠΌΠ΅ΠΉΠ½Π°Ρ Π΄ΠΎΠ±ΡΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½Π°Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠ° ΠΡΠΆΠ΅ΡΠΎ - Π₯Π΅ΠΉΠ»ΠΈ - Π₯Π΅ΠΉΠ»ΠΈ. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° Π±ΡΠ»Π»Π΅Π·Π½ΡΡ
Π΄Π΅ΡΠΌΠ°ΡΠΎΠ·ΠΎΠ² ΠΎΡΠ½ΠΎΠ²Π°Π½Π° Π½Π° ΠΎΡΠ΅Π½ΠΊΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ², ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΡΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ, Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΡΡΠΎΠ². ΠΠ΄Π½Π°ΠΊΠΎ Π½ΠΈ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· ΡΡΡΠ΅ΡΡΠ²ΡΡΡΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π² ΠΎΡΠ΄Π΅Π»ΡΠ½ΠΎΡΡΠΈ Π½Π΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ Ρ Π°Π±ΡΠΎΠ»ΡΡΠ½ΠΎΠΉ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΡΡΡΡ ΠΏΠΎΡΡΠ°Π²ΠΈΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΠ· ΠΏΡΠ·ΡΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ·Π°. ΠΠΎΡΡΠΎΠΌΡ Π΄Π»Ρ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΏΠΎΡΡΠ°Π½ΠΎΠ²ΠΊΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π° ΠΈ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΡ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ ΡΠΈΡΠΎΠΊΠΈΠΉ ΡΠΏΠ΅ΠΊΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ
ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π±Π΅Π»ΠΊΠ° PERP Π² ΠΊΠΎΠΆΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ
The authors disclosed the participation of apoptosis proteins in the development of acantholysis in patients with pemphigus. In this connection, studies of the PERP protein passing apoptosis signals and regulating desmosomal functions in keratinocytes are of interest. There is no information about any studies aimed at the PERP protein expression in patients with pemphigus in available literature. Goal. To assess the PERP protein expression in the skin of patients with pemphigus. Materials and methods. There was a study of 22 patients with pemphigus, a patient with bullous pemphigoid and ten healthy people. The PERP protein expression was studied in the biopsy materials obtained from lesion foci and apparently healthy skin of the patients as well as healthy people using the indirect immunofluorescence method. Results. The PERP protein expression was revealed in patients with pemphigus on areas of apparently intact skin, in lesion foci in the patient with bullous pemphigoid and skin of healthy volunteers in the membrane of keratinocytes from all epidermal layers.The PERP protein expression in the blister operculum in lesion foci in patients with pemphigus was absent. Conclusion. Substantial differences in the PERP protein expression in the blister operculum and apparently intact skin of patients with pemphigus were revealed.ΠΡΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠΎΠ²Π°Π½ΠΎ ΡΡΠ°ΡΡΠΈΠ΅ Π±Π΅Π»ΠΊΠΎΠ² Π°ΠΏΠΎΠΏΡΠΎΠ·Π° Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΠ·Π° ΠΏΡΠΈ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠ΅. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ Π²ΡΠ·ΡΠ²Π°Π΅Ρ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π±Π΅Π»ΠΊΠ° PERP, ΠΏΠ΅ΡΠ΅Π΄Π°ΡΡΠ΅Π³ΠΎ ΡΠΈΠ³Π½Π°Π»Ρ Π°ΠΏΠΎΠΏΡΠΎΠ·Π° ΠΈ ΡΠ΅Π³ΡΠ»ΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΡΠ½ΠΊΡΠΈΠΈ Π΄Π΅ΡΠΌΠΎΡΠΎΠΌ Π² ΠΊΠ΅ΡΠ°ΡΠΈΠ½ΠΎΡΠΈΡΠ°Ρ
. Π‘Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΎΠ± ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π±Π΅Π»ΠΊΠ° PERP Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ Π² ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΈ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΠΎΠΉ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ΅ ΠΎΡΡΡΡΡΡΠ²ΡΡΡ. Π¦Π΅Π»Ρ. ΠΡΠ΅Π½ΠΈΡΡ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π±Π΅Π»ΠΊΠ° PERP Π² ΠΊΠΎΠΆΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ 22 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ, 1 Π±ΠΎΠ»ΡΠ½ΠΎΠΉ Π±ΡΠ»Π»Π΅Π·Π½ΡΠΌ ΠΏΠ΅ΠΌΡΠΈΠ³ΠΎΠΈΠ΄ΠΎΠΌ ΠΈ 10 Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡ. Π Π±ΠΈΠΎΠΏΡΠ°ΡΠ°Ρ
, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΈΠ· ΠΎΡΠ°Π³ΠΎΠ² ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΈ Π²ΠΈΠ΄ΠΈΠΌΠΎ Π·Π΄ΠΎΡΠΎΠ²ΠΎΠΉ ΠΊΠΎΠΆΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΡ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡ, ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π½Π΅ΠΏΡΡΠΌΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠΈΠΈ ΠΈΠ·ΡΡΠ°Π»ΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π±Π΅Π»ΠΊΠ° PERP. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π±Π΅Π»ΠΊΠ° PERP Π²ΡΡΠ²Π»Π΅Π½Π° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ Π½Π° ΡΡΠ°ΡΡΠΊΠ°Ρ
Π²ΠΈΠ΄ΠΈΠΌΠΎ Π½Π΅ΠΏΠΎΡΠ°ΠΆΠ΅Π½Π½ΠΎΠΉ ΠΊΠΎΠΆΠΈ, Π² ΠΎΡΠ°Π³Π΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ Π±ΡΠ»Π»Π΅Π·Π½ΡΠΌ ΠΏΠ΅ΠΌΡΠΈΠ³ΠΎΠΈΠ΄ΠΎΠΌ ΠΈ Π² ΠΊΠΎΠΆΠ΅ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² Π½Π° ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π΅ ΠΊΠ΅ΡΠ°ΡΠΈΠ½ΠΎΡΠΈΡΠΎΠ² Π²ΡΠ΅Ρ
ΡΠ»ΠΎΠ΅Π² ΡΠΏΠΈΠ΄Π΅ΡΠΌΠΈΡΠ°. ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π±Π΅Π»ΠΊΠ° PERP Π² ΠΏΠΎΠΊΡΡΡΠΊΠ΅ ΠΏΡΠ·ΡΡΡ Π² ΠΎΡΠ°Π³Π°Ρ
ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ ΠΎΡΡΡΡΡΡΠ²ΠΎΠ²Π°Π»Π°. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Ρ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΡΠ°Π·Π»ΠΈΡΠΈΡ Π² ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π±Π΅Π»ΠΊΠ° PERP Π² ΠΏΠΎΠΊΡΡΡΠΊΠ΅ ΠΏΡΠ·ΡΡΡ ΠΈ Π²ΠΈΠ΄ΠΈΠΌΠΎ Π½Π΅ΠΏΠΎΡΠ°ΠΆΠ΅Π½Π½ΠΎΠΉ ΠΊΠΎΠΆΠ΅ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ
Π Π²ΠΎΠΏΡΠΎΡΠ°ΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ (Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ) ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ
True (acantholytic) pemphigus is an autoimmune disease characterized by blisters and erosions in the skin and/or mucous tunics. True (acantholytic) pemphigus can be diagnosed based on an assessment of clinical manifestations and results of cytology, histology and immunology tests. The current diagnostics methods are characterized by certain advantages and shortcomings yet none of them has 100% sensitivity and specificity. To diagnose pemphigus, a complex of studies is needed taking into consideration the body of clinical symptoms and laboratory indices.ΠΡΡΠΈΠ½Π½Π°Ρ (Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠ°Ρ) ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠ° - Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠ΅Π΅ΡΡ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠ·ΡΡΠ΅ΠΉ ΠΈ ΡΡΠΎΠ·ΠΈΠΉ Π½Π° ΠΊΠΎΠΆΠ΅ ΠΈ/ΠΈΠ»ΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠ°Ρ
. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ (Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ) ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ ΠΎΡΠ½ΠΎΠ²Π°Π½Π° Π½Π° ΠΎΡΠ΅Π½ΠΊΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ², ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΡΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ, Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΡΡΠΎΠ². Π‘ΡΡΠ΅ΡΡΠ²ΡΡΡΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈΠΌΠ΅ΡΡ ΡΠ²ΠΎΠΈ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ, Π½ΠΎ Π½ΠΈ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· Π½ΠΈΡ
Π² ΠΎΡΠ΄Π΅Π»ΡΠ½ΠΎΡΡΠΈ Π½Π΅ ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ 100% ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ ΠΈ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡΡ. ΠΠ»Ρ ΠΏΠΎΡΡΠ°Π½ΠΎΠ²ΠΊΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π° ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Ρ ΡΡΠ΅ΡΠΎΠΌ ΡΠΎΠ²ΠΎΠΊΡΠΏΠ½ΠΎΡΡΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ² ΠΈ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ
Π ΠΎΠ»Ρ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² Π³Π΅Π½Π° PERP Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΠ·Π° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ
Goal. To determine the nucleotide protein-coding PERP gene sequence and assess the relation between the revealed mutations/polymorphisms and development of true acantholytic pemphigus as well as particular features of its course. Materials and methods. The protein-coding PERP gene DNA sequence was studied by the sequence analysis method in 18 patients with true acantholytic pemphigus. Results. Two polymorphisms were discovered in patients with true acantholytic pemphigus in Exon 3 of the PERP gene for the first time: rs648802 (non-synonymous) and rs648396 (synonymous). The incidence of wild type genotypes in the revealed polymorphisms (Π‘/Π‘ genotype rs648802 and Π’/Π’ genotype rs648396) in healthy volunteers reliably exceeded that in patients (p = 0.049). Patients with true acantholytic pemphigus are characterized by a higher incidence rate of mutant heterozygous genotypes Π‘/G rs648802 and Π’/C rs648396 (p = 0.09). Mutant heterozygous genotypes of the polymorphisms (G/G genotype rs648802 and Π‘/Π‘ genotype rs648396) were revealed in patients with the earlier onset of the disease (41-60 years) (p = 0.025) more often while heterozygous genotypes (Π‘/G genotype rs648802 and T/Π‘ genotype rs648396) were revealed when the disease developed at the age of 61 or older more often (p = 0.01). Conclusion. Identification of the polymorphous genotype by the sequence method or other molecular methods (e.g. PCR) can be used to forecast the terms when true acantholytic pemphigus can emerge in genetically inclined patients. However, it should be noted that it is necessary to specify the preliminary results obtained based on a greater sample of patients with true acantholytic pemphigus.Π¦Π΅Π»Ρ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π½ΠΎΠΉ Π±Π΅Π»ΠΎΠΊ-ΠΊΠΎΠ΄ΠΈΡΡΡΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π³Π΅Π½Π° PERP Ρ ΠΎΡΠ΅Π½ΠΊΠΎΠΉ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π²ΡΡΠ²Π»Π΅Π½Π½ΡΠΌΠΈ ΠΌΡΡΠ°ΡΠΈΡΠΌΠΈ/ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ°ΠΌΠΈ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌΠΈ Π΅Π΅ ΡΠ΅ΡΠ΅Π½ΠΈΡ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π° Π±Π΅Π»ΠΎΠΊ-ΠΊΠΎΠ΄ΠΈΡΡΡΡΠ°Ρ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΠΠ Π³Π΅Π½Π° PERP Ρ 18 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΏΠ΅ΡΠ²ΡΠ΅ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ Π² 3-ΠΌ ΡΠΊΠ·ΠΎΠ½Π΅ Π³Π΅Π½Π° PERP Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ Π΄Π²Π° ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ°: rs648802 (Π½Π΅ΡΠΈΠ½ΠΎΠ½ΠΈΠΌΠΈΡΠ½ΡΠΉ) ΠΈ rs648396 (ΡΠΈΠ½ΠΎΠ½ΠΈΠΌΠΈΡΠ½ΡΠΉ). Π§Π°ΡΡΠΎΡΠ° Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Β«Π΄ΠΈΠΊΠΎΠ³ΠΎΒ» ΡΠΈΠΏΠ° Π²ΡΡΠ²Π»Π΅Π½Π½ΡΡ
ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² (Π‘/Π‘ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648802 ΠΈ Π’/Π’ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648396) Ρ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΠΏΡΠ΅Π²ΡΡΠΈΠ»Π° ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π΄Π°Π½Π½ΡΡ
Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
(Ρ = 0,049). Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ ΠΎΡΠΌΠ΅ΡΠ΅Π½Π° ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΡ ΠΊ Π±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎΠΌΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΌΡΡΠ°Π½ΡΠ½ΡΡ
Π³Π΅ΡΠ΅ΡΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΡΡ
Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Π‘/G rs648802 ΠΈ Π’/C rs648396 (Ρ = 0,09). ΠΡΡΠ°Π½ΡΠ½ΡΠ΅ Π³ΠΎΠΌΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΡΠ΅ Π³Π΅Π½ΠΎΡΠΈΠΏΡ Π΄Π°Π½Π½ΡΡ
ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² (G/G Π³Π΅Π½ΠΎΡΠΈΠΏ rs648802 ΠΈ Π‘/Π‘ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648396) ΡΠ°ΡΠ΅ Π²ΡΡΠ²Π»ΡΠ»ΠΈΡΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π±ΠΎΠ»Π΅Π΅ ΡΠ°Π½Π½ΠΈΠΌ Π½Π°ΡΠ°Π»ΠΎΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ (41-60 Π»Π΅Ρ) (Ρ = 0,025), Π° Π³Π΅ΡΠ΅ΡΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΡΠ΅ Π³Π΅Π½ΠΎΡΠΈΠΏΡ (Π‘/G Π³Π΅Π½ΠΎΡΠΈΠΏ rs648802 ΠΈ T/Π‘ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648396) ΡΠ°ΡΠ΅ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°Π»ΠΈΡΡ ΠΏΡΠΈ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 61 Π³ΠΎΠ΄Π° ΠΈ ΡΡΠ°ΡΡΠ΅ (Ρ = 0,01). ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½ΠΎΡΠΈΠΏΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ»ΠΈ Π΄ΡΡΠ³ΠΈΠΌΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΌΠΈ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ (Π½Π°ΠΏΡΠΈΠΌΠ΅Ρ ΠΠ¦Π -ΠΠ€Π Π€) ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Π° Ρ ΡΠ΅Π»ΡΡ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΎΠΊΠΎΠ² ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΈ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ Ρ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΠ΄Π½Π°ΠΊΠΎ ΡΠ»Π΅Π΄ΡΠ΅Ρ ΠΏΠΎΠ΄ΡΠ΅ΡΠΊΠ½ΡΡΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΡΠΎΡΠ½Π΅Π½ΠΈΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠ΅Π΄Π²Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π½Π° Π±ΠΎΠ»Π΅Π΅ ΠΊΡΡΠΏΠ½ΠΎΠΉ Π²ΡΠ±ΠΎΡΠΊΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ
Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ Π²ΡΠ»ΡΠ³Π°ΡΠ½ΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ Π½Π° Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
Pemphigus vulgaris is a chronic autoimmune bullous disease characterized by the formation of blisters on the skin and/ or mucous tunics as a result of acantholysis. To search for new molecular and biological targets, study pathogenetic mechanisms of the disease development and develop new methods of treatment, it is urgent to create an experimental model of pemphigus in laboratory animals reproducing clinical, histological and immunological signs of pemphigus. Goal of the study. To develop an experimental model of pemphigus by injecting IgG produced from the blood serum taken from patients with pemphigus to neonatal mice of the BALB/c inbred line. Results. Accumulated IgG products taken from patients with pemphigus (main groups) and healthy volunteers (control group) were injected intraperitoneally to neonatal mice of the BALB/Ρ in the doses of 10-30 mg per mouse. Clinical, histological and immunomorphological signs of pemphigus were revealed in the mice from the main group, which received intraperitoneal injections of IgG taken from patients with pemphigus in the dose of 30 mg per mouse. No signs of pemphigus were observed in the mice from the control group, which received injections of IgG taken from healthy people. This study confirms the role of pemphigus autoantibodies in the pathogenesis of pemphigus vulgaris and shows that passive transmission of antibodies to laboratory animals is possible.ΠΡΠ»ΡΠ³Π°ΡΠ½Π°Ρ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠ° - Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΠΎΠ΅ Π±ΡΠ»Π»Π΅Π·Π½ΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠ΅Π΅ΡΡ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠ·ΡΡΠ΅ΠΉ Π½Π° ΠΊΠΎΠΆΠ΅ ΠΈ/ΠΈΠ»ΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠ°Ρ
Π²ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΠ·Π°. ΠΠ»Ρ ΠΏΠΎΠΈΡΠΊΠ° Π½ΠΎΠ²ΡΡ
ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠΈΡΠ΅Π½Π΅ΠΉ, ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ Π½ΠΎΠ²ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌ ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ Π½Π° Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
, Π²ΠΎΡΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ΅ΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ. Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ ΠΏΡΡΠ΅ΠΌ Π²Π²Π΅Π΄Π΅Π½ΠΈΡ Π½Π΅ΠΎΠ½Π°ΡΠ°Π»ΡΠ½ΡΠΌ ΠΌΡΡΠ°ΠΌ ΠΈΠ½Π±ΡΠ΅Π΄Π½ΠΎΠΉ Π»ΠΈΠ½ΠΈΠΈ BALB/c ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² IgG, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΈΠ· ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠ²ΠΎΡΠΎΠΆΠ΄Π΅Π½Π½ΡΠΌ ΠΌΡΡΠ°ΠΌ Π»ΠΈΠ½ΠΈΠΈ BALB/Ρ Π²Π½ΡΡΡΠΈΠ±ΡΡΡΠΈΠ½Π½ΠΎ Π²Π²Π΅Π΄Π΅Π½Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ ΡΡΠΌΠΌΠ°ΡΠ½ΡΡ
IgG, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ (ΠΎΡΠ½ΠΎΠ²Π½Π°Ρ Π³ΡΡΠΏΠΏΠ°) ΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² (ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ Π³ΡΡΠΏΠΏΠ°), Π² Π΄ΠΎΠ·Π°Ρ
ΠΎΡ 10 Π΄ΠΎ 30 ΠΌΠ³/ΠΌΡΡΡ. Π£ ΠΌΡΡΠ΅ΠΉ ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ, ΠΏΠΎΠ»ΡΡΠ°Π²ΡΠΈΡ
Π²Π½ΡΡΡΠΈΠ±ΡΡΡΠΈΠ½Π½ΡΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ IgG ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ Π² Π΄ΠΎΠ·Π΅ 30 ΠΌΠ³/ΠΌΡΡΡ, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ. Π£ ΠΌΡΡΠ΅ΠΉ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ, ΠΊΠΎΡΠΎΡΡΠΌ Π²Π²ΠΎΠ΄ΠΈΠ»ΠΈΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ IgG Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡ, ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ Π½Π΅ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈΡΡ. ΠΠ°Π½Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°Π΅Ρ ΡΠΎΠ»Ρ ΠΏΠ΅ΠΌΡΠΈΠ³ΡΡΠ½ΡΡ
Π°ΡΡΠΎΠ°Π½ΡΠΈΡΠ΅Π» Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ Π²ΡΠ»ΡΠ³Π°ΡΠ½ΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ ΠΈ ΠΏΠΎΠΊΠ°Π·ΡΠ²Π°Π΅Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΏΠ°ΡΡΠΈΠ²Π½ΠΎΠΉ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ Π°Π½ΡΠΈΡΠ΅Π» Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΠΌ ΠΆΠΈΠ²ΠΎΡΠ½ΡΠΌ
METHODS FOR FORMING PROFESSIONAL COMPETENCIES IN FUTURE PROGRAMMERS
The presented article is devoted to the formation of professional competencies in future programmers. The relevance of the research is based on the fact that information technologies are used in all spheres of life of modern society, therefore, specialists who can develop and code algorithms for working with information are in great demand. Algorithms form the basis of any information protection process, labor efficiency calculations, therefore it becomes important to form competencies in future IT specialists related to the ability to program using various programming languages and methods, using the main types and data structures from the everyday practice of programmers. As indicators of the effectiveness of methods for the formation of professional competencies, there are competencies: knowledge of modern trends in the development of tools and software; the presence of theoretical knowledge and practical skills that allow you to build an algorithm, analyze its work with different input data and implement it using modern programming languages; the ability to use high-level PL and professional programming systems, tools for solving professional-applied problems in the information sphere of the enterprise. The article deals with traditional and developed by the author methods of teaching programmin
Combination of the transurethral resection and prostate HIFU ablation at treatment of the localized cancer
Research objective: to estimate results of treatment of patients with the localized form of a cancer of a prostate at a combination of a transurethral resection (TURP) and HIFU of an ablation. Objects and research methods: From February, 2009 to February, 2014 of 100 patients with the localized form of a cancer of a prostate were selected for research:
26 patients were included into HIFU and 74 group in group of the combined treatment (TURP+HIFU). Selection criteria for HIFU ablation were the localized cancer of a prostate concerning which earlier it wasn't carried out treatments, and level of a PSA at the time of statement of the diagnosis 15 ng/ml. All patients corresponding to these by criteria, were considered as candidates for treatment and inclusion in the analysis. The nadir and stability of PSA, the histologic conclusion, IPSS, quality of life and complication were estimated at time of postoperative supervision. Results: Statistically significant influence of a combination TURP+HIFU for the term of transurethral drainage of a bladder (a median of 40 days against 7 days), incontience frequency (15.4% against 6.9%), infections of urinary ways (47.9% against 11.4%) and IPSS change during the postoperative period (on the average 8.91 against 3.37) is noted. During the short period of supervision it wasn't observed considerable changes in relation to efficiency: in HIFU group the frequency of repeated sessions made 25%, in TUR/HIFU group 4%. Conclusion: HIFU therapy is modern, minimum invasive method of a cancer therapy of a prostate. The combination of a transurethral resection and HIFU ablation significantly reduces the frequency of the complications connected with treatment. Maintaining the patient after combined TURP and HIFU ablation is comparable with maintaining the patient after usual TURP